US Stock MarketDetailed Quotes

VRCA Verrica Pharmaceuticals

Watchlist
  • 1.010
  • +0.020+2.06%
Trading Nov 22 11:18 ET
91.51MMarket Cap-549P/E (TTM)

Verrica Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-161.06%-1.78M
2,744.51%5.18M
10,240.54%3.83M
-43.27%5.12M
2,823.53%1.99M
-64.94%2.92M
-14.95%182K
-91.42%37K
-24.73%9.03M
68K
Operating revenue
-161.06%-1.78M
2,744.51%5.18M
10,240.54%3.83M
-43.27%5.12M
2,823.53%1.99M
-64.94%2.92M
-14.95%182K
-91.42%37K
-24.73%9.03M
--68K
Cost of revenue
61.11%435K
298.53%542K
1,573.53%1.14M
2.90%746K
338.71%272K
62.65%270K
-37.90%136K
-75.54%68K
725K
62K
Gross profit
-183.72%-2.22M
9,976.09%4.64M
8,770.97%2.69M
-47.30%4.38M
28,500.00%1.72M
-67.53%2.65M
1,020.00%46K
-120.26%-31K
-30.78%8.31M
6K
Operating expense
-30.40%18.49M
70.13%19.84M
201.60%21.29M
128.36%67.6M
258.94%22.32M
296.18%26.56M
27.93%11.66M
-6.68%7.06M
-31.01%29.6M
-26.60%6.22M
Selling and administrative expenses
-19.80%16.08M
178.29%16.52M
278.31%16.34M
171.79%47.31M
432.93%17M
410.93%20.05M
14.77%5.94M
-15.61%4.32M
-35.49%17.41M
-37.63%3.19M
Research and development costs
-63.06%2.41M
-42.03%3.32M
80.65%4.95M
66.38%20.3M
75.69%5.32M
134.17%6.51M
45.19%5.73M
12.02%2.74M
-23.42%12.2M
-9.80%3.03M
Operating profit
13.43%-20.7M
-30.91%-15.21M
-162.36%-18.6M
-196.87%-63.22M
-231.65%-20.6M
-1,751.73%-23.92M
-27.35%-11.62M
4.33%-7.09M
31.10%-21.3M
26.67%-6.21M
Net non-operating interest income expense
-158.08%-2.16M
-415.50%-1.98M
-444.20%-1.72M
27.95%-1.22M
-629.02%-1.51M
-1,346.27%-835K
159.85%626K
147.17%500K
59.35%-1.7M
126.73%286K
Non-operating interest income
-73.11%221K
-37.22%393K
19.60%598K
475.63%2.74M
176.92%792K
455.41%822K
3,030.00%626K
2,172.73%500K
286.99%476K
959.26%286K
Non-operating interest expense
43.39%2.38M
--2.37M
--2.32M
82.41%3.96M
--2.31M
1,945.68%1.66M
--0
--0
-49.43%2.17M
--0
Other net income (expense)
98.00%-1K
-5K
-11K
-70.64%-2.55M
-35,642.86%-2.5M
96.51%-50K
-1.5M
-7K
Special income (charges)
----
----
----
-76.55%-2.54M
----
----
----
----
---1.44M
--0
-Less:Other special charges
----
----
----
----
----
----
----
----
--1.44M
--0
-Gain on sale of property,plant,equipment
----
----
----
---2.54M
----
----
----
----
--0
----
Other non- operating income (expenses)
98.00%-1K
---5K
---11K
75.86%-14K
600.00%35K
-1,100.00%-50K
----
----
---58K
---7K
Income before tax
7.83%-22.86M
-56.38%-17.19M
-208.56%-20.33M
-173.59%-67M
-314.94%-24.61M
-29,981.93%-24.8M
-8.08%-10.99M
22.21%-6.59M
30.20%-24.49M
37.82%-5.93M
Income tax
Net income
7.83%-22.86M
-56.38%-17.19M
-208.56%-20.33M
-173.59%-67M
-314.94%-24.61M
-29,981.93%-24.8M
-8.08%-10.99M
22.21%-6.59M
30.20%-24.49M
37.82%-5.93M
Net income continuous Operations
7.83%-22.86M
-56.38%-17.19M
-208.56%-20.33M
-173.59%-67M
-314.94%-24.61M
-29,981.93%-24.8M
-8.08%-10.99M
22.21%-6.59M
30.20%-24.49M
37.82%-5.93M
Minority interest income
Net income attributable to the parent company
7.83%-22.86M
-56.38%-17.19M
-208.56%-20.33M
-173.59%-67M
-314.94%-24.61M
-29,981.93%-24.8M
-8.08%-10.99M
22.21%-6.59M
30.20%-24.49M
37.82%-5.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
7.83%-22.86M
-56.38%-17.19M
-208.56%-20.33M
-173.59%-67M
-314.94%-24.61M
-29,981.93%-24.8M
-8.08%-10.99M
22.21%-6.59M
30.20%-24.49M
37.82%-5.93M
Basic earnings per share
9.26%-0.49
-54.17%-0.37
-193.33%-0.44
-105.56%-1.48
-285.71%-0.54
-26,326.32%-0.54
35.14%-0.24
51.61%-0.15
44.62%-0.72
60.00%-0.14
Diluted earnings per share
9.26%-0.49
-54.17%-0.37
-193.33%-0.44
-105.56%-1.48
-285.71%-0.54
-26,339.07%-0.54
35.14%-0.24
51.61%-0.15
44.62%-0.72
60.00%-0.14
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -161.06%-1.78M2,744.51%5.18M10,240.54%3.83M-43.27%5.12M2,823.53%1.99M-64.94%2.92M-14.95%182K-91.42%37K-24.73%9.03M68K
Operating revenue -161.06%-1.78M2,744.51%5.18M10,240.54%3.83M-43.27%5.12M2,823.53%1.99M-64.94%2.92M-14.95%182K-91.42%37K-24.73%9.03M--68K
Cost of revenue 61.11%435K298.53%542K1,573.53%1.14M2.90%746K338.71%272K62.65%270K-37.90%136K-75.54%68K725K62K
Gross profit -183.72%-2.22M9,976.09%4.64M8,770.97%2.69M-47.30%4.38M28,500.00%1.72M-67.53%2.65M1,020.00%46K-120.26%-31K-30.78%8.31M6K
Operating expense -30.40%18.49M70.13%19.84M201.60%21.29M128.36%67.6M258.94%22.32M296.18%26.56M27.93%11.66M-6.68%7.06M-31.01%29.6M-26.60%6.22M
Selling and administrative expenses -19.80%16.08M178.29%16.52M278.31%16.34M171.79%47.31M432.93%17M410.93%20.05M14.77%5.94M-15.61%4.32M-35.49%17.41M-37.63%3.19M
Research and development costs -63.06%2.41M-42.03%3.32M80.65%4.95M66.38%20.3M75.69%5.32M134.17%6.51M45.19%5.73M12.02%2.74M-23.42%12.2M-9.80%3.03M
Operating profit 13.43%-20.7M-30.91%-15.21M-162.36%-18.6M-196.87%-63.22M-231.65%-20.6M-1,751.73%-23.92M-27.35%-11.62M4.33%-7.09M31.10%-21.3M26.67%-6.21M
Net non-operating interest income expense -158.08%-2.16M-415.50%-1.98M-444.20%-1.72M27.95%-1.22M-629.02%-1.51M-1,346.27%-835K159.85%626K147.17%500K59.35%-1.7M126.73%286K
Non-operating interest income -73.11%221K-37.22%393K19.60%598K475.63%2.74M176.92%792K455.41%822K3,030.00%626K2,172.73%500K286.99%476K959.26%286K
Non-operating interest expense 43.39%2.38M--2.37M--2.32M82.41%3.96M--2.31M1,945.68%1.66M--0--0-49.43%2.17M--0
Other net income (expense) 98.00%-1K-5K-11K-70.64%-2.55M-35,642.86%-2.5M96.51%-50K-1.5M-7K
Special income (charges) -------------76.55%-2.54M-------------------1.44M--0
-Less:Other special charges ----------------------------------1.44M--0
-Gain on sale of property,plant,equipment ---------------2.54M------------------0----
Other non- operating income (expenses) 98.00%-1K---5K---11K75.86%-14K600.00%35K-1,100.00%-50K-----------58K---7K
Income before tax 7.83%-22.86M-56.38%-17.19M-208.56%-20.33M-173.59%-67M-314.94%-24.61M-29,981.93%-24.8M-8.08%-10.99M22.21%-6.59M30.20%-24.49M37.82%-5.93M
Income tax
Net income 7.83%-22.86M-56.38%-17.19M-208.56%-20.33M-173.59%-67M-314.94%-24.61M-29,981.93%-24.8M-8.08%-10.99M22.21%-6.59M30.20%-24.49M37.82%-5.93M
Net income continuous Operations 7.83%-22.86M-56.38%-17.19M-208.56%-20.33M-173.59%-67M-314.94%-24.61M-29,981.93%-24.8M-8.08%-10.99M22.21%-6.59M30.20%-24.49M37.82%-5.93M
Minority interest income
Net income attributable to the parent company 7.83%-22.86M-56.38%-17.19M-208.56%-20.33M-173.59%-67M-314.94%-24.61M-29,981.93%-24.8M-8.08%-10.99M22.21%-6.59M30.20%-24.49M37.82%-5.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 7.83%-22.86M-56.38%-17.19M-208.56%-20.33M-173.59%-67M-314.94%-24.61M-29,981.93%-24.8M-8.08%-10.99M22.21%-6.59M30.20%-24.49M37.82%-5.93M
Basic earnings per share 9.26%-0.49-54.17%-0.37-193.33%-0.44-105.56%-1.48-285.71%-0.54-26,326.32%-0.5435.14%-0.2451.61%-0.1544.62%-0.7260.00%-0.14
Diluted earnings per share 9.26%-0.49-54.17%-0.37-193.33%-0.44-105.56%-1.48-285.71%-0.54-26,339.07%-0.5435.14%-0.2451.61%-0.1544.62%-0.7260.00%-0.14
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-1.03%